Ackman Defends Gray Area Bid for Allergan
Activist investor Bill Ackman defended his nontraditional role in Valeant Pharmaceuticals International Inc.'s bid for Allergan Inc. on Monday, citing his own compromises to get a deal done....To view the full article, register now.
Already a subscriber? Click here to view full article